Study of viral integration of HPV-16 in young patients with LSIL

Aims: To investigate the physical status of human papillomavirus 16 (HPV-16) in low grade squamous intraepithelial lesions (LSILs) as a means of determining the percentage of viral integration. Methods: Ninety two LSIL/HPV positive Thin Prep™ samples were initially tested for the E6 gene by the poly...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical pathology Vol. 56; no. 7; pp. 532 - 536
Main Authors Gallo, G, Bibbo, M, Bagella, L, Zamparelli, A, Sanseverino, F, Giovagnoli, M R, Vecchione, A, Giordano, A
Format Journal Article
LanguageEnglish
Published London BMJ Publishing Group Ltd and Association of Clinical Pathologists 01.07.2003
BMJ
BMJ Publishing Group Ltd
BMJ Publishing Group LTD
Copyright 2003 Journal of Clinical Pathology
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Aims: To investigate the physical status of human papillomavirus 16 (HPV-16) in low grade squamous intraepithelial lesions (LSILs) as a means of determining the percentage of viral integration. Methods: Ninety two LSIL/HPV positive Thin Prep™ samples were initially tested for the E6 gene by the polymerase chain reaction (PCR) to identify the HPV-16 virus. To avoid false positive results, the specificity of the bands obtained from PCR was confirmed by Southern blot hybridisation with internal oligonucleotide probes. Next, a PCR screen for the E2 gene was performed to identify those samples in which the virus was integrated. Viral integration was detected in just over half of them. Results: Twenty of the 92 samples were HPV-16 positive, as shown by PCR for the E6 gene. Southern blot analysis confirmed that 13 of these samples were positive for the viral E6 gene. Thus, viral integration was detected in just over a half of the samples positive for HPV-16. Conclusions: These data show that HPV-16 integration occurs in a subset of LSILs. The measurement of HPV-16 integration would be a helpful complementary tool for cytological evaluation in primary cervical screening to identify those patients at risk of developing high grade squamous intraepithelial lesions and cervical cancer.
Bibliography:istex:BCE42B4A974A746A8B1A87E6F3A0D1A8EBB3242A
Correspondence to:
 Dr G Gallo, College of Science and Technology, Temple University, BioLife Science Bldg Suite 333, 1900 N 12th Street, Philadelphia, PA 19122, USA; 
 gaia.gallo@spr-r.it
ark:/67375/NVC-P61K2G9K-5
local:0560532
href:jclinpath-56-532.pdf
PMID:12835300
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Correspondence to: … Dr G Gallo, College of Science and Technology, Temple University, BioLife Science Bldg Suite 333, 1900 N 12th Street, Philadelphia, PA 19122, USA; …gaia.gallo@spr-r.it
ISSN:0021-9746
1472-4146
DOI:10.1136/jcp.56.7.532